HOMEPostContact Us
Posted June 17. 2013 2:33PM

U.S. Supreme Court slaps big pharma for paying generic makers to delay lower cost medications

Click headline or here to open angled item
Ruled 5-3 that agreements between the makers of name-brand and generic drugs to delay the generics' availability can be illegal, an outcome cheered by consumer groups.


1015,1027,1130,1061